FDA Clearance Tracker · P150016-S019
Tridyne Vascular Sealant
Last checked: Nov 20, 2026Latest source record: Aug 17, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Aug 17, 2021
Approved
Time to decision
238 days
Received Dec 22, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150016-S019
- Device name
- Tridyne Vascular Sealant
- Applicant
- Neomend, Inc.
- Applicant location
- Irvine, CA
- Received
- Dec 22, 2020
- Decided
- Aug 17, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150016
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for replacing the 5mL sterile water vial with a 10mL vial.
Source documents
Other decisions for Neomend, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P150016 · Decided Apr 11, 2016 · 350 days after receipt
Device type: Sealant, polymerizing (NBE) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.